Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Sangui BioTech International, Inc. (OTC: SGBI).

Full DD Report for SGBI

You must become a subscriber to view this report.



Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-14N/A0.025N/AN/A0
2018-12-13N/A0.025N/AN/A0
2018-12-12N/A0.025N/AN/A0
2018-12-11N/A0.025N/AN/A0
2018-12-10N/A0.025N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-11-281,30011,30011.5044Cover
2018-08-219,00059,00015.2542Cover
2018-07-18192,297203,50094.4948Short
2018-07-1719,655183,20010.7287Cover
2018-07-1020,00060,00033.3333Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on SGBI.


About Sangui BioTech International, Inc. (OTC: SGBI)

Logo for Sangui BioTech International, Inc. (OTC: SGBI)

Sangui invents and develops innovative proprietary medical and cosmetic products, and underpins these inventions with patents and testing. It is Sangui s strategy to place the legalization and subsequent marketing and distribution into the hands of competent specialists and to collect revenues mainly from royalties.

 

Contact Information

 

 

Current Management

  • Thomas Striepe / CEO
    • THOMAS STRIEPE, is Vice President Accounting and Controlling at Dr. Ludz GmbH, Hamburg, Germany, a financial services company. Prior to joining Dr. Ludz GmbH in , he held management positions in the accounting departments of several German and international corporations. He holds an MBA of Hamburg University
  • Hubertus Schmelz / HUBERTUS SCHMELZ, is the General Manager of SanguiBioTech GmbH. He was appointed to this position effective December , . Prior to joining Sangui he acted as a legal and business consultant. During the last decade prior to he was entrusted with numerous business development projects by the German Treuhandanstalt in restructuring the economy of Eastern Germany. After having studied law he acted as legal counsel in several positions.
  • Thomas Striepe / THOMAS STRIEPE, is Vice President Accounting and Controlling at Dr. Ludz GmbH, Hamburg, Germany, a financial services company. Prior to joining Dr. Ludz GmbH in , he held management positions in the accounting departments of several German and international corporations. He holds an MBA of Hamburg University

Current Share Structure

  • Market Cap: $6,595,803 - 03/14/2018
  • Authorized: 250,000,000 - 03/14/2018
  • Issue and Outstanding: 188,451,503 - 03/14/2018
  • Float: 167,483,902 - 05/17/2017

 


Recent Filings from (OTC: SGBI)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 03 2018
Prospectus filed under Rule 424(b)(3)
Filing Type: 424B3Filing Source: edgar
Filing Date: May, 03 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: February, 13 2018
Prospectus filed under Rule 424(b)(3)
Filing Type: 424B3Filing Source: edgar
Filing Date: February, 13 2018
Prospectus filed under Rule 424(b)(3)
Filing Type: 424B3Filing Source: edgar
Filing Date: November, 21 2017
Prospectus filed under Rule 424(b)(3)
Filing Type: 424B3Filing Source: edgar
Filing Date: November, 21 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 20 2017
Notification that form 10-Q will be submitted late
Filing Type: NT 10-QFiling Source: edgar
Filing Date: November, 14 2017
OTCQB Certification - OTCQB Certification
Filing Type: OTCQB Certification - OTCQB CertificationFiling Source: OTC Markets
Filing Date: November, 09 2017
Prospectus filed under Rule 424(b)(3)
Filing Type: 424B3Filing Source: edgar
Filing Date: October, 18 2017

 

 


Daily Technical Chart for (OTC: SGBI)

Daily Technical Chart for (OTC: SGBI)


Stay tuned for daily updates and more on (OTC: SGBI)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: SGBI)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in SGBI is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of SGBI and does not buy, sell, or trade any shares of SGBI. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/